Optimal Starting Time for Flutamide to Prevent Disease Flare in Prostate Cancer Patients Treated with a Gonadotropin-Releasing Hormone Agonist

Publisher： Karger

E-ISSN： 1423-0399|66|3|135-139

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.66, Iss.3, 2001-04, pp. : 135-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Use of Gonadotropin-Releasing Hormone Agonist in a Patient with Pulmonary Endometriosis

By  

Respiration, Vol. 66, Iss. 6, 1999-11 ,pp. : 544-546

Karger

Access to resources Recommend Favorite

Dienogest compared with gonadotropin‐releasing hormone agonist after conservative surgery for endometriosis

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 42, Iss. 9, 2016-09 ,pp. : 1152-1158

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dual trigger with gonadotropin‐releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin‐releasing hormone antagonist cycles

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 42, Iss. 9, 2016-09 ,pp. : 1146-1151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Failure to Maintain a Suppressed Level of Serum Testosterone during Long-Acting Depot Luteinizing Hormone-Releasing Hormone Agonist Therapy in Patients with Advanced Prostate Cancer

By  

Urologia Internationalis, Vol. 77, Iss. 2, 2006-08 ,pp. : 135-138

Karger

Access to resources Recommend Favorite

Model of gonadotropin-releasing hormone and gonadotropin-releasing hormone complex

By Wiwanitkit Viroj  

Sexuality and Disability, Vol. 24, Iss. 3, 2006-09 ,pp. : 175-178

Springer Publishing Company

Access to resources Recommend Favorite